Editorial & Evidence Policy

Last updated: 19 September 2026

Pharmatropia publishes product information and educational content to help customers make more informed choices. This policy explains how we separate product facts from general ingredient research, how we handle health claims, which sources we prefer and how readers can request a correction.

Our core principles

Product facts must be product-specific. A statement about a Pharmatropia product should be supported by its current label, formulation, specification, supplier documentation or an appropriate finished-product test.
Ingredient research is not product proof. A laboratory study, clinical trial or review about an ingredient does not automatically prove that every commercial product containing that ingredient produces the same result.
Evidence strength should be clear. We distinguish established medical use, human clinical evidence, preliminary research, traditional use and marketing claims.
Safety is part of usefulness. Relevant medicine interactions, contraindications, pregnancy cautions and reasons to seek professional advice should not be hidden behind promotional language.
No invented credentials or certifications. Author titles, reviewer qualifications, laboratory tests, approvals and certifications are included only when they can be confirmed.

How we research health and supplement topics

Depending on the question, we prioritise:

Official medicine labels, safety communications and guidance from recognised regulators.
Systematic reviews, clinical guidelines and high-quality evidence summaries.
Peer-reviewed human studies that match the ingredient, form, route and outcome being discussed.
Primary laboratory or animal research when it provides useful background, clearly labelled as preliminary and not presented as proof of a human benefit.
Documented traditional use, described in its cultural and historical context without converting tradition into a modern disease-treatment claim.

We avoid relying on anonymous marketing pages, copied marketplace descriptions or a single study presented without its limitations.

How we write about Pharmatropia products

Product pages should make it easy to verify what is being sold. Where relevant, we aim to show the product format, declared ingredient, strength or pack size, directions, storage information, important warnings and links to available quality documentation.

Terms such as “USP grade”, “independently tested”, “Halaal certified” or similar quality statements apply only where the underlying product or documentation supports them. A quality specification does not mean that a product is approved to diagnose, treat, cure or prevent disease.

Prices, stock, formulations and pack sizes can change. The current product page and physical label take priority over older articles, flyers or cached search results.

Claims we do not treat as established

We do not present a supplement as proven to reverse ageing, repair DNA, cure disease, guarantee weight loss, replace prescribed treatment or produce a particular cognitive, cardiovascular or athletic result unless that exact claim is supported for the exact product and is lawful to make. Words such as “may”, “supports” and “wellness” do not turn an unsupported claim into good evidence.

Medical and safety boundaries

Pharmatropia’s educational content is not personalised medical advice. Readers should consult an appropriately qualified healthcare professional when they use prescription medicine, have a medical condition, are preparing for surgery, are pregnant or breastfeeding, or are considering a product with important interactions.

Urgent symptoms require appropriate medical assessment. Website content should not delay emergency care or encourage a reader to start, stop or change prescribed medicine.

Methylene Blue content standard

Content about Methylene Blue must clearly distinguish established clinical uses of pharmaceutical methylene blue from oral wellness products. It should prominently address serotonergic medicine interactions and G6PD deficiency. Research about mitochondrial or redox mechanisms must not be presented as proof that a retail capsule treats a cognitive, infectious, neurological or age-related condition.

Nitric Oxide content standard

Content about nitric oxide supplements should identify the actual ingredients in the product rather than treating all “nitric oxide boosters” as equivalent. It should distinguish nitrate-based products from amino-acid formulas and explain relevant cautions for people using nitrate medicines, PDE-5 inhibitors, blood-pressure medicines or other cardiovascular treatment.

Authorship and review

Articles should identify the author or responsible publisher. A professional review credit is included only when the named person has reviewed that specific page and their role or qualification can be confirmed. Publication and review dates may be shown where available.

Commercial pages may link to products sold by Pharmatropia. This commercial relationship does not change the evidence standard: product availability is not proof of efficacy.

Corrections and updates

We review high-risk safety content and key commercial pages when formulations, labels, guidance or important evidence changes. We may also update internal links, comparisons and explanations to make them clearer.

If you believe a page contains an inaccurate product fact, unsupported claim, outdated warning or missing disclosure, please contact Pharmatropia with the page URL and the point that needs review. Where a material correction is confirmed, we update the page rather than preserving an inaccurate statement.